seroquel restless leg syndrome
TOPLINE: In insulin-naive people with type 2 diabetes, once-weekly icodec titrated with a dosing guide app was both noninferior and superior to daily basal analogs in reducing A1c levels, with improved treatment satisfaction and compliance scores and similarly low hypoglycemia rates. METHODOLOGY: A 52-week, randomized, open-label, parallel-group, lisinopril surdosage phase 3a trial with real-world elements was conducted at 176 sites […]
Continue reading »